Cargando…
Yaffe and Aranda's neonatal and pediatric pharmacology : therapeutic principles in practice /
"Textbook in pediatric pharmacology and provides evidence-based guidelines for safe, effective, and rational drug therapy in newborns, children, and adolescents"--
| Clasificación: | Libro Electrónico |
|---|---|
| Autores principales: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Philadelphia :
Wolters Kluwer,
[2021]
|
| Edición: | Fifth edition. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBSCO_on1341396978 | ||
| 003 | OCoLC | ||
| 005 | 20231017213018.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 220819s2021 paua ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d N$T |d OCLCF |d OCLCQ |d TFW |d FHJ |d OCLCO | ||
| 020 | |a 9781975112493 |q (electronic bk.) | ||
| 020 | |a 1975112490 |q (electronic bk.) | ||
| 020 | |z 9781975112486 |q hardcover | ||
| 020 | |z 1975112482 |q hardcover | ||
| 035 | |a (OCoLC)1341396978 | ||
| 050 | 4 | |a RJ560 | |
| 060 | 4 | |a WS 366 | |
| 082 | 0 | 4 | |a 615.1083 |2 23 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Aranda, Jacob V., |e author. | |
| 245 | 1 | 0 | |a Yaffe and Aranda's neonatal and pediatric pharmacology : |b therapeutic principles in practice / |c Jacob (Jack) Aranda, MD, PhD, FRCPC, FAAP, Johannes (John) van den Ankerr, MD, PhD, FCP, FAAP. |
| 250 | |a Fifth edition. | ||
| 264 | 1 | |a Philadelphia : |b Wolters Kluwer, |c [2021] | |
| 300 | |a 1 online resource : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 500 | |a Revision of: Neonatal and pediatric pharmacology / [edited by] Sumner J. Yaffe, Jacob V. Aranda. c2010. 4th ed. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | 0 | |g Section I: |t General principles. |t Clinical trials involving children: history, rationale, regulatory framework, and technical considerations ; |t Clinical pharmacokinetics in infants and children ; |t Developmental pharmacodynamics, receptor function, and drug actions in newborns and children ; |t Drug absorption, distribution, metabolsim, excretion, and transporters in newborns and children ; |t Pharmacogenetics, pharmacogenomics, and pharmacoproteomics in newborns and children ; |t Ethics of drug research in newborns and children ; |t Precision medicie and therapeutic drug monitoring ; |t Drug formulations for children -- |g Section II: |t Pharmacology in special settings and population: the newborn. |t Role of placenta in drug metabolism and drug transfer ; |t Maternal medications during pregnancy and lactation ; |t Principles of neonatal pharmacology ; |t Renal function and excretion of drugs in the newborn ; |t Neuroprotective drugs and perinatal brain injury ; |t Pharmacologic agents for neonatal hyperbilirubinemia ; |t Pharmacologic treatment of neonatal apnea -- |g Section III: |t Pharmacology in special settings and population. |t Therapeutic applications in pediatric intensive care ; |t Drug therapy in the pediatric emergency department ; |t Topical medications ; |t Ophthalmologic drugs in infants and children -- |g Section IV: |t Antimicrobial pharmacology. |t Penicillins, cephalosporins, and other [beta]-lactams ; |t Glycopeptides, lipoglycopeptides, and lipopeptides ; |t Aminoglycosides ; |t Macrolides, clindamycin, and oxazolidinones ; |t Fluoroquinolones ; |t Sulfonamides, dihydrofolate reductase inhibitors, and dapsone ; |t Tetracyclines, chloramphenicol, and metronidazole ; |t Antimalarials ; |t Anthelminthics drugs in children ; |t Antimycobacterial drugs (mycobacterium tuberculosis and atypical mycobacteria) ; |t Antifungal agents ; |t Antivirals in newborns and children ; |t Pharmacology of antiretroviral drugs in pregnant and breastfeeding women and their newborns -- |g Section V: |t Neuropharmacology. |t Anticonvulsants ; |t Antidepressants and mood stabilizers ; |t Stimulants, ADHD treatments, and antipsychotics ; |t Analgesics and sedatives ; |t Pharmacologic management of neonatal abstinence syndrome ; |t Local anesthetic agents for regional and superficial anesthesia in infants, children and adolescents -- |g Section VI: |t Immunopharmacology, allergy, and inflammation. |t Nonsteroida anti-inflammatory drugs ; |t Antihistamine drugs ; |t Antiasthmatics ; |t Immunosuppressive and immunomodulatory drugs -- |g Section VII: |t Pharmacology of biologic drugs. |t Microbial therapeutics: beyond probiotics ; |t Monoclonal antibiotics ; |t Stem cells ; |t Drugs, lung development, and pulmonary surfactant ; |t Childhood vaccines -- |g Section VIII: |t Cardiorenal drugs. |t Neonatal cardiovascular pharmacology ; |t Antiarrhythmic drugs: disorders of cardiac rhythm and pharmacologic management ; |t Antihypertensive drugs ; |t Diuretics -- |g Section IX: |t Gastrointestinal pharmacology. |t Gastrointestinal drugs ; |t Drugs in inflammatory bowel disease -- |g Section X: |t Endocrine and hematologic pharmacology. |t Glucocorticoids ; |t Insulin and diabetes ; |t Growth hormone ; |t Thyroid hormones ; |t Hematologic agents ; |t Clinical pharmacology of antineoplastic drugs -- |g Section XI: |t Nutritional pharmacology, pharmacotoxidromes, adverse drug reactions, and interactions. |t Nutrient supplements ; |t Herbal drugs in children ; |t Pediatric poisonings and antidotes ; |t Adverse drug reactions in newborns and children ; |t Medication errors in children ; |t Drug interactions in newborns and children -- |g Appendix A1: |t Neonatal drug formulary -- |g Appendix A2: |t Pediatric drug formulary. |
| 520 | |a "Textbook in pediatric pharmacology and provides evidence-based guidelines for safe, effective, and rational drug therapy in newborns, children, and adolescents"-- |c Provided by publisher. | ||
| 588 | 0 | |a Online resource; title from PDF title page (EBSCOhost platform, viewed March 31, 2023). | |
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 650 | 0 | |a Pediatric pharmacology. | |
| 650 | 0 | |a Children |x Diseases |x Chemotherapy. | |
| 650 | 0 | |a Chemotherapy. | |
| 650 | 0 | |a Children. | |
| 650 | 0 | |a Infants. | |
| 650 | 0 | |a Drugs |x Dosage. | |
| 650 | 2 | |a Drug Therapy | |
| 650 | 2 | |a Child | |
| 650 | 2 | |a Infant | |
| 650 | 2 | |a Pharmaceutical Preparations |x administration & dosage | |
| 650 | 2 | |a Pharmacological Phenomena | |
| 650 | 6 | |a Pharmacologie pédiatrique. | |
| 650 | 6 | |a Enfants |x Maladies |x Chimiothérapie. | |
| 650 | 6 | |a Chimiothérapie. | |
| 650 | 6 | |a Enfants. | |
| 650 | 6 | |a Nourrissons. | |
| 650 | 6 | |a Posologie. | |
| 650 | 7 | |a children (people by age group) |2 aat | |
| 650 | 7 | |a infants. |2 aat | |
| 650 | 7 | |a Children |x Diseases |x Chemotherapy |2 fast | |
| 650 | 7 | |a Pediatric pharmacology |2 fast | |
| 700 | 1 | |a Van den Anker, John N., |e author. | |
| 776 | 0 | 8 | |i Print version: |a Aranda, Jacob V. |t Yaffe and Aranda's neonatal and pediatric pharmacology. |b Fifth edition. |d Philadelphia : Wolters Kluwer, [2021] |z 9781975112486 |w (DLC) 2020028621 |w (OCoLC)1162186883 |
| 856 | 4 | 0 | |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3241830 |z Texto completo |
| 938 | |a EBSCOhost |b EBSC |n 3241830 | ||
| 994 | |a 92 |b IZTAP | ||